Evolent Health Q3 Adj. EPS $(0.09) Beats $(0.12) Estimate, Sales $220.1M Beat $217.9M Estimate

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.12) by 25 percent. This is a 125 percent decrease over losses of $(0.04) per share from the same

Benzinga · 11/05/2019 21:08

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.12) by 25 percent. This is a 125 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $220.1 million which beat the analyst consensus estimate of $217.9 million by 1.01 percent. This is a 46.58 percent increase over sales of $150.161 million the same period last year.